bioAffinity Technologies (BIAF) announced that it has closed its previously announced best efforts offering of securities for aggregate gross proceeds to the company of $3.25M, before deducting agent fees and other estimated expenses payable by the company. The offering consisted of 10,156,250 shares of Common Stock, together with warrants to purchase up to 15,234,375 shares of Common Stock. The combined public offering price for each share of common stock and accompanying May 2025 Warrant is 32c. WallachBeth Capital, LLC acted as sole placement agent for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIAF:
- BioAffinity Technologies announces pricing of $3.25M offering
- BioAffinity Technologies files to sell 7.01M shares of common stock, warrants
- bioAffinity Technologies Board Member Announces Departure
- bioAffinity Technologies Reports Record Revenue for 2024
- BioAffinity Technologies downgraded to Hold from Buy at Maxim